Coronavirus: China approves first homegrown vaccine, despite limited data on its efficacy


Source: newshub.co.nz newshub.co.nz

Key Topics in this News Article:

News Snapshot:

Watch: World Health Organization warns vaccinated travellers should still have to quarantine. Credits: Video - Newshub; Image - Reuters China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter. No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said on Wednesday its vaccine was 79.34 percent effective in preventing people from developing the disease based on interim data....